Pfizer Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2012
Total Assets: $185.80B
Liabilities Breakdown FY2012
Total Liabilities: $104.12B
Asset Breakdown
Total Assets: $185.80B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $10.08B | 5.4% |
| Accounts Receivable | $10.68B | 5.7% |
| Inventory | $6.08B | 3.3% |
| Property, Plant & Equipment | $13.21B | 7.1% |
| Goodwill | $43.66B | 23.5% |
| Intangible Assets | $45.15B | 24.3% |
| Other Assets | $56.95B | 30.6% |
Liabilities Breakdown
Total Liabilities: $104.12B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.92B | 2.8% |
| Long-Term Debt | $31.04B | 29.8% |
| Other Liabilities | $70.16B | 67.4% |